PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-17.13%
Negative revenue growth while FSLR stands at 44.62%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-56.88%
Negative gross profit growth while FSLR is at 33.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
64.12%
EBIT growth 1.25-1.5x FSLR's 45.73%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
-44.93%
Negative operating income growth while FSLR is at 45.73%. Joel Greenblatt would press for urgent turnaround measures.
26.00%
Net income growth at 75-90% of FSLR's 30.12%. Bill Ackman would press for improvements to catch or surpass competitor performance.
-294.44%
Negative EPS growth while FSLR is at 30.28%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
86.35%
Diluted EPS growth above 1.5x FSLR's 30.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.04%
Share reduction while FSLR is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.06%
Diluted share count expanding well above FSLR's 0.06%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-39.92%
Negative OCF growth while FSLR is at 239.19%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-89.21%
Negative FCF growth while FSLR is at 277.34%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-61.22%
Negative 10Y revenue/share CAGR while FSLR stands at 40.36%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.05%
Negative 5Y CAGR while FSLR stands at 64.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.50%
3Y revenue/share CAGR under 50% of FSLR's 88.62%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-159.44%
Negative 10Y OCF/share CAGR while FSLR stands at 171.79%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
13.70%
Below 50% of FSLR's 396.83%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-281.16%
Negative 3Y OCF/share CAGR while FSLR stands at 198.71%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-185.83%
Negative 10Y net income/share CAGR while FSLR is at 398.22%. Joel Greenblatt sees a major red flag in long-term profit erosion.
85.92%
Below 50% of FSLR's 557.58%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-106.52%
Negative 3Y CAGR while FSLR is 199.39%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-81.01%
Negative equity/share CAGR over 10 years while FSLR stands at 38.26%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
218.02%
5Y equity/share CAGR above 1.5x FSLR's 25.90%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-26.48%
Negative 3Y equity/share growth while FSLR is at 20.15%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.64%
Firm’s AR is declining while FSLR shows 78.83%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.39%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.93%
Negative asset growth while FSLR invests at 8.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-27.56%
We have a declining book value while FSLR shows 6.10%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.38%
Debt shrinking faster vs. FSLR's 14.92%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-11.23%
Our R&D shrinks while FSLR invests at 6.49%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
8.26%
SG&A growth well above FSLR's 13.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.